Trial Profile
Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2023
Price :
$35
*
At a glance
- Drugs L-Acetylleucine (Primary)
- Indications Ataxia telangiectasia
- Focus Therapeutic Use
- Sponsors IntraBio
- 29 Aug 2023 Planned End Date changed from 1 Jul 2023 to 1 Mar 2025.
- 29 Aug 2023 Planned primary completion date changed from 1 Jul 2023 to 1 Dec 2024.
- 28 Feb 2023 Planned End Date changed from 1 Mar 2023 to 1 Jul 2023.